Angiolink Corporation
About:
Angiolink privately held medical device company focused on developing innovative wound closure solutions for vascular procedures.
Website: http://www.angiolink.com/
Top Investors: Bioventures Investors, Boston Financial & Equity Corporation, IDP Industrial Development Partners, JHK Investments
Description:
Angiolink Corporation offers EVS vascular closure system, an arterial stapling device for use in closing holes and punctures made in arteries in connection with the catheter-based surgical procedures, such as angioplasty and angiograms.
Total Funding Amount:
$24.2M
Headquarters Location:
Taunton, Massachusetts, United States
Founded Date:
1999-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2003-09-10
IPO Status:
Private
Industries:
© 2025 bioDAO.ai